Miniatura

Fitxers

TFG_QU Pruñonosa Martin, Laia.pdf (1.01 MB)

Tipus de document

Treball de fi de grau

Data de publicació

2021-01

Llicència de publicació

cc-by-nc-nd (c) Pruñonosa, 2021
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/175258

Remdesivir, Favipiravir and Sinefungin, three nucleosidic products with potential antiviral properties against SARS-CoV-2

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

Resum

In December 2019, an outbreak of pneumonia of unknown origin was reported in Wuhan, China. The causing agent was promptly recognised as a new coronavirus (CoV) titled as SARS-CoV-2. The accelerated set of scientific findings on SARS-CoV-2 provided in a record time a meaningful amount of potential drug targets. Current promising strategies to pharmacologically target SARS-CoV-2 are vaccines and repurposing drugs. Repurposing antivirals have the advantage of accelerated market approval because of the previously broad knowledge of the drug's behaviour in humans and the feasibility of combining the repurposed drugs with other ones to reach much more effective treatments. Nonetheless, more therapeutic trials are required to establish whether these drugs are indeed efficacious and safe against SARS-CoV-2. In this TFG report, through a previous analysis of the biology and activity of the virus, we will review three current potential antivirals against SARS-CoV-2: Remdesivir, Favipiravir and Sinefungin. Concretely, the chemical methodologies adopted for either development and synthesis, mode of biological action and therapeutic and pharmacological properties will be specifically treated for each antiviral

Descripció

Treballs Finals de Grau de Química, Facultat de Química, Universitat de Barcelona, Any: 2021, Tutor: Jordi Robles Brau

Matèries

COVID-19, SARS-CoV-2, Medicaments antivírics, Treballs de fi de grau

Matèries (anglès)

COVID-19, SARS-CoV-2, Antiviral agents, Bachelor's theses

Citació

Col·leccions

Treballs Finals de Grau (TFG) - Química

Citació

PRUÑONOSA MARTIN, Laia. Remdesivir, Favipiravir and Sinefungin, three nucleosidic products with potential antiviral properties against SARS-CoV-2. [consulta: 20 de gener de 2026]. [Disponible a: https://hdl.handle.net/2445/175258]

Exportar metadades

JSON - METS

Compartir registre